Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 93 (4) , 842-854
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Thermally Targeted Delivery of a c-Myc Inhibitory Polypeptide Inhibits Tumor Progression and Extends Survival in a Rat Glioma ModelPLOS ONE, 2013
- Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approachAmerican Journal of Physiology-Renal Physiology, 2012
- Human Endothelial Progenitor CellsCold Spring Harbor Perspectives in Medicine, 2011
- Renal Microvascular Disease Determines the Responses to Revascularization in Experimental Renovascular DiseaseCirculation: Cardiovascular Interventions, 2010
- Renal capsule as a stem cell nicheAmerican Journal of Physiology-Renal Physiology, 2010
- Endothelial Progenitor Cells Homing and Renal Repair in Experimental Renovascular DiseaseStem Cells, 2010
- Role of renal microcirculation in experimental renovascular diseaseNephrology Dialysis Transplantation, 2009
- Increased hypoxia and reduced renal tubular response to furosemide detected by BOLD magnetic resonance imaging in swine renovascular hypertensionAmerican Journal of Physiology-Renal Physiology, 2009
- Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular DiseaseCirculation, 2009
- The biology of VEGF and its receptorsNature Medicine, 2003